Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More

Defense Dept. Funds Ketamine Study For PTSD Treatment A DOD Health Agency-funded adaptive platform trial for alternative treatments for PTSD will test SLS-002 on some 600 active-duty service members

BenzingaDec 5, 2023 10:12 ET

Irwin Naturals GAAP EPS of -$0.56, Revenue of $19.1M

Seeking AlphaNov 28, 2023 10:55 ET

Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses

Irwin Naturals Inc. (CSE:IWIN) (OTC:IWINF) (FRA: 97X), a nutraceutical company leveraging its brand into the cannabis and psychedelics sectors, reported its financial results for the third quarter of

BenzingaNov 28, 2023 08:50 ET